Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiation in vitro

Human Gene Therapy

Volumn 8, Issue 4, 1997, Pages 467-475

  Xu, Liang ^a   Pirollo, Kathleen F ^a   Chang, Esther H ^a,b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME; PROTEIN P53; TRANSFERRIN;

ARTICLE; CANCER RADIOTHERAPY; DNA TRANSFECTION; GENETIC TRANSDUCTION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IONIZING RADIATION; RADIOSENSITIZATION; SQUAMOUS CELL CARCINOMA;

MUS MUSCULUS;

EID: 0030895405     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.4-467     Document Type: Article

References (28)

1. AMERICAN CANCER SOCIETY. (1993). American Cancer Society Facts and Figures, Publ. No. 93-400 (American Cancer Society, Washington, DC).
2. BOULIKAS, T. (1996). Liposome DNA delivery and uptake by cells. Oncol. Reports 3, 1-7.
3. BRACHMAN, D.G. (1994). Molecular biology of head and neck cancer. Semin. Oncol. 21, 320-329.
4. CHANG, F., SYRJANEM, S., and SYRJANEM, K. (1995). Implications of the p53 tumor-suppressor gene in clinical oncology. J. Clin. Oncol. 13, 1009-1022.
5. CHENG, P. (1996). Receptor ligand-facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin. Hum. Gene Ther. 7, 275-282.
6. CHRISTIANO, R.J., and CURIEL, D.T. (1996). Strategies to accomplish gene therapy via the receptor-mediated endocytosis pathway. Cancer Gene Ther. 3, 490-457.
7. CLARKE, A.R., PURDIE, C.A., HARRISON, D.J., MORRIS, R.G., BIRD, C.C., HOOPER, M.L., and WYLLIE, A.H. (1993). Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 262, 849-852.
8. DIMERY, I.W., and HONG, W.K. (1993). Overview of combined modality therapies for head and neck cancer. J. Natl. Cancer Inst. 85, 95-111.
9. ELLIOT, R.L., ELLIOT, M.C., WANG, F., and HEAD, J.F. (1993). Breast carcinoma and the role of iron metabolism. A cytochemical, tissue culture, and ultrastructural study. Ann. NY Acad. Sci. 698, 159-166.
10. FARHOOD, H., GAO, X., SON, K., YANG, Y., LAZO, J.S., and HUANG, L. (1994). Cationic liposomes for direct gene transfer in therapy of cancer and other diseases. Ann. NY Acad. Sci. 716, 23-35.
11. FELGNER, P.L., TSAI, Y.J., SUKHU, L., WHEELER, C.J., MANTHORPE, M., et al. (1995). Improved cationic lipid formulations for in vivo gene therapy. Ann. NY Acad. Sci. 771, 126-138.
12. HAMADA, K., ALEMANY, R., ZHANG, W.W., HITTELMAN, W.N., LOTAN, R., ROTH, J.A., and MITCHELL, M.F. (1996). Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer. Cancer Res. 56, 3047-3054.
13. KASTAN, M.B., ONYEKWERE, O., SIDRANSKY, D., VOGELSTEIN, B., and CRAIG, R.W. (1991). Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311.
14. KUERBITZ, S.J., PLUNKETT, B.S., WALSH, W.V., and KASTAN, M.B. (1992). Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89, 7491-7495.
15. LEDLEY, F.D. (1995). Nonviral gene therapy: The promise of genes as pharmaceutical products. Hum. Gene Ther. 6, 1129-1144.
16. LEE, J.M., and BERNSTEIN, A. (1993). P53 mutations increase resistance to ionizing radiation. Proc. Natl. Acad. Sci. USA 90, 5742-5746.
17. LESOON-WOOD, L.A., HO KIM, W., KLEINMAN, H.K., WEINTRAUB, B.D., and MIXSON, A.J. (1995). Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice. Hum. Gene Ther. 6, 395-405.
18. LEVINE, A.J., MOMAND, J., and FINLAY, C.A. (1991). The p53 tumor suppressor gene. Nature 351, 453-456.
19. LEWIS, J.G., LIN, K., KOTHAVALE, A., FLANAGAN, W.M., and MATTEUCCI, M.D. (1996). A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc. Natl. Acad. Sci. USA 93, 3176-3181.
20. LOWE, S.W. (1995). Cancer therapy and p53. Curr. Opin. Oncol. 7, 547-553.
21. LOWE, S.W., SCHMITT, E.M., SMITH, S.W., OSBORNE, B.A., and JACKS, T. (1993). P53 is required for radiation induced apoptosis in mouse thymocytes. Nature 362, 847-848.
22. LOWE, S.W., BODIS, S., McCLATCHEY, A., REMINGTON, L., RULEY, H.E., FISHER, D.E., HOUSMAN, D.E., and JACKS, T. (1994). P53 status and the efficacy of cancer therapy in vivo. Science 266, 807-810.
23. MIYAMOTO, T., TANAKA, N., EISHI, Y., and AMAGASA, T. (1994). Transferrin receptor in oral tumors. Int. J. Oral Maxillofac. Surg. (Denmark). 23, 430-433.
24. McILWRATH, A.J., VASEY, P.A., ROSS, G.M., and BROWN, R. (1994). Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Res. 54, 3718-3722.
25. O'CONNER, P.M., JACKMAN, J., JONDLE, D., BHATIA, K., MAGRATH, I., and KOHN, K.W. (1993). Role of p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's Lymphoma cell lines. Cancer Res. 53, 4776-4780.
26. THORSTENSEN, K., and ROMSLO, I. (1993). The transferrin receptor: Its diagnostic value and its potential as therapeutic target. Scand. J. Clin. Lab. Invest. Suppl. (Norway) 215, 113-120.
27. WEICHSELBAUM, R.R., BECKETT, M.A., SCHWARTZ, J.L., and DRITSCHILO, A. (1988). Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 15, 575-579.
28. YANG, C., CIRIELLI, C., CAPOGROSSI, M.C., and PASSANITT, A. (1995). Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells. Cancer Res. 55, 4210-4213.